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Abstract
Objective Quality improvement (QI) is increasingly featuring in the United
Kingdom (UK) National Health Service (NHS) agenda to promote safety, effec-
tiveness and patient experience. However, the use of QI techniques by health-
care professionals appears limited and constrained with only isolated examples
of good practice. This study explores QI within the pharmacy context. Focusing
on the community pharmacy ‘Healthy Living Pharmacy scheme’, this study
aims to explore changes in QI understanding resulting from a postgraduate QI
educational intervention.
Methods Four focus groups were held involving 13 community pharmacists
enrolled onto a newly developed postgraduate QI educational module. Two
focus groups were held before and two after the module’s completion. Knowl-
edge of QI and practical applications following the learning was explored.
Key findings Three themes emerged: pharmacists’ motivation for learning
about QI, conceptual understanding and translation into practice. Pharmacists
expressed positive views about learning new skills but expressed logistical con-
cerns about how they would accommodate the extra learning. Prior knowledge
of QI was found to be lacking and its application in practice ineffectual. Fol-
lowing completion of the QI module, significant improvements in comprehen-
sion and application were seen. Pharmacists considered it too soon to make an
assessment on patient outcomes as their improvements required time to effec-
tively embed changes in practice.
Conclusions Quality improvement forms an important part of the NHS qual-
ity and safety agenda; however, community pharmacists may not currently have
adequate knowledge of QI principles. The postgraduate educational interven-
tion showed promising results in pharmacist’s knowledge, organisational cul-
ture and application in practice.
Introduction
Healthcare educators are seeking effective approaches to
delivering care that is reliable, safe and within a quality
improvement (QI) framework.[1,2] This involves the appli-
cation of evidence-based tools that can be applied to work
practices to enhance the quality and delivery of care.[3]
Whilst the definition of quality varies, within the NHS
and other healthcare systems ‘quality’ is about ensuring
that health care is safe, patient-centred, timely, efficient
and equitable.[4,5] Alongside educators, a range of stake-
holders (e.g. healthcare professionals, managers, commis-
sioners, policy makers, researchers) should take ownership
implementing QI.[6] There is an expectation that QI tech-
niques should be an integral part of routine work in order
for healthcare professionals to constantly improve their
services; however, at present there appears to be only iso-
lated examples of good practice.[3] It has been
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acknowledged that training should be offered in the
science of safety and quality methods if QI is to be imple-
mented in a sustainable fashion.[7] Yet, currently there is
a lack of coherent approaches to QI, both in training and
organisational culture.[7]
To reduce variability in QI delivery, healthcare profes-
sionals require an understanding of the application of
evidence-based QI methods in practice.[8] This has
become more pronounced following the Mid-Stafford-
shire inquiry.[9] This inquiry was commissioned in 2010
to investigate shortfalls in patient care in one UK hospi-
tal. The subsequent recommendations included that QI
methods should be incorporated into the curricula to
develop professional responsibility and safety.[9] In
response, formal QI methods training is being pro-
moted.[10] It has been shown that didactic learning is
less likely to be effective compared to workplace driven
QI training.[11,12] A United States (US) survey study
investigated the impact of a continuous QI programme
in community pharmacies. The survey aimed to assess
changes in attitudes towards patient safety culture and
frequency of quality-related events. Despite its small
sample, the programme was shown to increase self-re-
ported patient safety culture attitudes among pharmacy
staff.[13] However, little is known about how QI is con-
textualised and fostered within the UK community phar-
macy context or to what extent newly learnt principles
can be applied to practice. This qualitative study aims to
explore the view of community pharmacists who had
enrolled onto a QI training module and investigates their
understanding of QI principles and how their learning
has impacted on practice.
Healthy Living Pharmacy scheme
We focus attention on one English community pharmacy
initiative known as the Healthy Living Pharmacy (HLP)
scheme. This is a nationally commissioned initiative that
attempts to support the delivery of a range of services to
improve public health by providing self-care advice, treat-
ment for common ailments and healthy lifestyle interven-
tions.[14] Under the scheme, the pharmacy provides
patients with health information, brief counselling and
support on wide-ranging issues related to healthy living
and well-being and is coordinated by a trained HLP
champion.[15] The HLP scheme is part of a wider ‘Phar-
macy Quality Scheme (PQS)’ which incentivises pharma-
cies financially to achieve a set of defined quality criteria
covering three quality dimensions of patient safety, clini-
cal effectiveness and patient experience.[16] These aims are
in line with continued ambitions to prevent disease, tackle
health inequalities, encourage cost-effective health care
and to utilise pharmacy services better.[17,18]
Despite positive reports of pharmacies adopting the
HLP scheme[14,19] and HLP ‘champions’ feeling empow-
ered to engage with public health and well-being
issues,[20] significant barriers to effective implementation
have been reported. This includes low patient and public
awareness, lack of trained staff and poor organisational
infrastructure to deliver the scheme effectively.[21,22] It is
unknown how these barriers are impacting on service
quality. Given the majority of pharmacies in England have
signed up to become an HLP and that the service is pre-
sently being delivered suboptimally, it was decided that
this scheme would be ideal for demonstrating the impact
of the application of QI methods in order to improve
HLP practices.
Method
Aim
This qualitative study aimed to explore the views of com-
munity pharmacists who had enrolled on a postgraduate
QI module. We investigated a priori and posteriori
knowledge and understanding of QI and reflections on its
application in practice.
Postgraduate Quality Improvement
educational module
It was hypothesised that a postgraduate QI module that
provided pharmacists with methodological training in the
principles of QI could be used to address the suboptimal
delivery of HLP services. The module was developed and
delivered by TA and supported by SG and NG. It was to
be studied over a 6-month period via virtual distance
learning. To support the learning, three face-to-face study
days were delivered. Pharmacists were eligible to enrol if
they were a practising community pharmacist (working at
least 15 hours per week) in the Derbyshire area. Pharma-
cists were encouraged to develop and adopt a culture of
quality care using formal QI methods (i.e. root cause
analysis tools). Further details of the module description
objectives can be found in Table 1.
The module was funded by Health Education England
(HEE) through the Pharmacy Integration Fund (PhIF)
and so pharmacists recieved the training for free. This
funding stream was set up by NHS England to support
the postgraduate education of community pharmacists to
improve patient outcomes.[23]
Study design
The QI module was advertised to all community pharma-
cies within the UK Derbyshire area. All pharmacists who
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expressed an interest and enrolled on to the postgraduate
QI module were invited to take part in the focus groups
to explore ideas, contrary opinions and new areas of
understanding.[24] All were provided with an information
sheet beforehand (via email) detailing the aims of the
research. A topic guide was developed from the literature
and focused on exploring QI knowledge and how QI
methods are used in practice (Appendix S1). For conve-
nience, focus groups were arranged to coincide with the
first and last face-to-face study days. Two focus groups,
lasting approximately 1 hour, were held at the first study
day (at a local hotel) and explored prior knowledge of QI
and the extent to which this was applied within their
HLP. Following completion of the QI module (at month
6), two further focus groups were held at the final face-
to-face study day (belonging to the same cohort) and
explored changes in QI understanding and the impact on
practice (Appendix S2). To allow each pharmacist to
explain in detail their understanding of QI and ways the
learning had influenced practice, it was decided that focus
groups should be small. With consent, all focus groups
were audio-recorded and field notes taken during and
after.
Reflexivity
To minimise bias and avoid influencing participant
responses, focus groups were led by AL and two pharma-
cist educators (SG and JH) who were not involvement in
teaching or managing the QI module. AL is male and has
a PhD in pharmacy practice research and extensive expe-
rience in qualitative methods. SG (male) and JH (female)
are pharmacists with experience of pharmacy practice
research.
Data analysis
All audio-recorded focus group discussions were tran-
scribed verbatim. Given the workload reported by phar-
macists, transcripts were not returned to participants for
cross-checking. The data were imported into qualitative
analysis package NVivo 9.[25] Using an interpretivist
methodology, which sought to position the meaning-mak-
ing practices of human actors at the centre of explana-
tions, a coding and a thematic analysis were then
undertaken.[26] This involved initial reading and rereading
of the transcribed data (by AL) to identify common codes
and categories. Codes were then compared for their inter-
nal consistency and boundaries. A coding framework
emerged iteratively (with codes focusing on QI knowledge
and its application in practice), and data systematically
coded according to this framework. To enhance the con-
sistency of analysis, all the coded data and analysis were
reviewed by a separate member of the research team
(NG). To enhance the credibility of the findings, all mem-
bers of the research team discussed and checked coher-
ence of the themes. The principle of constant comparison
was used to test and refine the empirical conceptual con-
sistency of codes and themes which were synthesised and
narrated.
Findings
Participants
Thirteen community pharmacists enrolled on the QI
module of which 11 attended the first study day and took
part in the prefocus groups. The postfocus groups
involved five participants (Table 2).
Table 1 Details and learning outcomes of postgraduate QI module
Module
description
Quality improvement
Delivered by Leicester School of Pharmacy (De Montfort
University)
Degree Level
and Credit
Postgraduate Level 7
Delivery mode Online distance learning, with tutor support and 3
interactive face-to-face events
Duration Six (6) months
Indicative
content/
Areas of
study
• Clinical pharmacy management: health policy,
healthcare organisation and management
• Audit techniques
• Clinical governance and how it relates to phar-
maceutical services including training and audit-
ing to drive service enhancement
• Risk management, dispensing and medication
errors, the causes, theory and investigation of
medication errors
• Service operation and delivery – service improve-
ment, models of pharmacy practice, quality man-
agement theory and performance
Learning
outcomes
• Critically review, using quality management
methods, the provision of a chosen pharmaceuti-
cal service or provision
• Appraise the strengths and weakness of the cur-
rent service
• Devise a proposal, based on critical review and
appraisal, to enable the service to be enhanced.
Assess clinical governance principles, risk man-
agement and local and/ or national policies and
priorities relating to the service
• Generate and implement SMART improvements
to the chosen service
• Plan the assessment or reaudit of the improved
service
• Critically analyse operational and personal devel-
opment
Assessment • 3000-word report
• Portfolio of evidence
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Pharmacist motivation
Participants reported a variety of reasons for enrolling on
the module including opportunities for networking, learn-
ing from others, developing transferable skills and ensuring
they were ‘up-to-date’ with NHS advances. Some simply
wanted to take advantage of the funded training available,
whilst others emphasised wanting to challenge themselves,
enhance their employability and learn something new:
I think if we learn a little more about quality
improvement then we’ll hopefully have the tools at
our fingertips to enable us to do it more effectively
and efficiently. Because at the minute we don’t
really know where to start [FG1_Female_28yrs]
After completing the module, most reported having to
use their own time, with some using holiday entitlement,
to complete the learning. There were instances where par-
ticipants did not feel fully supported by their managers
due to worries over how the extra learning could nega-
tively impact on existing duties. Despite these challenges,
all participants enjoyed learning about QI and felt
empowered through their knowledge of QI tools. There
was also a sense of collegial working with fellow students.
After completing the module, many felt encouraged to
undertake further studies and saw this training as a means
to enhance leadership skills and career prospects:
I enjoyed discovering the new tools . . .that I had
no idea about. I like the fact that I’ve gained skills
for my CV . . . I find it actually helps me grow as a
professional and increases my networking abilities
[FG3_Female_28yrs]
I agree with [name], in that I’ve become a better
leader because I’m looking at deeper issues than I
was before [FG3_Female_28yrs]
Understanding QI
Our second theme explores changes in participant under-
standing of QI and how this had developed after the
training. Prior knowledge of QI was variable and limited
with all participants reporting not having received any
specific QI training. Some perceived QI to mean improve-
ments to quality of patient care, better management of
processes and identifying risks and reducing errors.
For me quality improvement is looking at current
practice, what you are doing like what recipes you’re
following to make it better. You need to look at the
improvement side of it as well. You’re not stuck with
the same recipes or procedures that you’re following,
you are looking at how it can be improved by looking
at different programs [FG1_Male_32yrs].
Others were unclear on how to define the term. For
example, they perceived QI to be ‘guidelines to be fol-
lowed’ or patient feedback on their performance. There
was confusion that QI referred to improving the range of
services to patients:
Well I just thought it was the different schemes
running, like the MUR [Medicines Use Review]and
NMS[New Medicine Service] that were hopefully
improving the quality of care that people receive.
[FG1_Female_51yrs]
When participants were asked how they thought they
applied QI, this was through audits. Workload pressures
meant they did not have time to effectively engage with QI
nor was there room for critical reflection with their teams:
The only chance you get to do that is 10 minutes
before you open or 15 minutes after you close, but
by that time half your staff have probably gone
home. No one wants to stay. [FG1_Male_31yrs]
Table 2 Demographic details of pharmacists enrolled onto the module
Participant ID
Gender (M = Male,
F = Female)
Participant age
(years) Pharmacy type
Participation in
prefocus group
Participation in
postfocus group
1 M 31 Small multiple √
2 F 28 Large multiple √ √
3 F 24 Large multiple √ √
4 M 32 Large multiple √ √
5 M 34 Small multiple √
6 M 34 Large multiple √ √
7 M 27 Small multiple √
8 M 45 Large multiple √
9 F 25 Large multiple √
10 M 47 Independent √
11 M 32 Large multiple √
12 M 33 Large multiple
13 F 51 Large multiple √
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Quality improvement almost scares me because I
just don’t really know what I’m doing and what
I’m supposed to be doing. . .[FG1_Female_51yrs]
After completing the module, participants’ application
and understanding of QI appeared to have significantly
improved, being able to comprehensively define the scope
of QI and its value to patients.
Now my understanding is that it’s applying a series
of tools to any given situation or service, and then
analysing the current service to help you pose
changes and solutions to make the service better
using set tools that are outlined by NHS England
. . . now I think more about patient outcomes.
[FG3_Female_28yrs]
Specifically, they showed greater self-reflection on their
practice, recognising the limitation of current systems of
governance. For instance, the pharmacy’s written standard
operating procedures (SOP) were viewed in a new light
and seen as an inadequate means to enhancing QI:
Traditionally we have the SOPs built up by somebody
in the company. We don’t really break down into
details to see if there’s any problem [FG4_Male_32yrs]
Translating QI learning to improve Health
Living Pharmacy (HLP) activities
Our final theme considers the impact QI training had on
practice. Before the training, participants were asked about
how HLP activities were run in their pharmacies. They
reported nominating a ‘healthy living champion’ who
tended to single-handedly promote the HLP initiative.
They had a notice board area where promotional materials
for public health campaigns were displayed. There was
common agreement that the HLP initiative was suboptimal
due to poor patient awareness and expectations:
We have more 60 year old patients, they don’t care
about anything, they don’t look at the board; all
they want is their prescriptions [FG1_Male_32yrs]
After the learning, participants’ accounts suggested that they
were using QI to undertake a more proactive and investigatory
approach to practice. They actively sought to involve their
teams through mapping and redesigning processes which
appeared to be changing their pharmacy’s culture in making
both their HLP and other services safer and more efficient:
I think this project has helped me to change the
way I practise . . .Now I involve all the staff, even
my counter assistants. Everyone involved gives their
ideas and now it’s made everything easier and the
service can be improved quicker [FG4_Male_34yrs]
Participants suggested that it was too early to assess
impact on patient experiences and outcomes since their
proposed changes require time to imbed in practice.
Discussion
This study showed that in the sample of community
pharmacists who participated, prior conceptual knowledge
of QI was lacking and its application in practice ineffec-
tual. On completion of the module, pharmacist’s knowl-
edge and comprehension of QI appeared to improve and
they were able to demonstrate the application of QI prin-
ciples to the healthy living service. The pedagogical
approach of workplace learning alongside face-to-face
group learning resulted in improvements in attitudes, cul-
ture and service delivery. Nevertheless, it was acknowl-
edged that pharmacists felt it was too early to assess the
impact on patient outcomes.
To our knowledge, this is the only UK study that has
explored the assessment of a postgraduate QI intervention
on community pharmacist’s understanding of QI and inves-
tigated its impact on practice. The main limitation to this
study is that only five participants out of the original 13
attended the follow-up focus groups. Six participants with-
drew from the module due to personal reasons and workload
pressures, and so, the findings should be viewed with caution
as it is uncertain that data saturation was reached. In addi-
tion, our sample included pharmacists that had voluntarily
enrolled onto the course and so may have been more moti-
vated to engage with the learning. The views therefore
expressed may not be representative of all pharmacists.
The finding add to the growing literature on QI. Despite
QI forming an important part of the NHS quality and safety
agenda,[3,10] QI principles are poorly applied in routine
practice.[27] There is debate on how best to train health pro-
fessionals in QI methods,[12] especially in the light of phar-
macists reported difficulties undertaking new learning due
to lack of time or other organisational constraints.[28,29,30]
Despite the constraints, the learning was perceived to be
beneficial and in line with findings from other studies. For
example, in one Canadian study, a community pharmacist
educational intervention (including the use of supportive QI
tools) demonstrated that improvements in pharmacy opera-
tional processes could result in reduced incidences of medi-
cation errors/near misses.[31] In an Australian study, a
community pharmacy QI intervention had potential to
improve the safety of dose administration aids to nursing
homes and reduced the occurrence of dispensing errors.[32]
Our findings also suggested improvements, but any assess-
ment of patient-related outcomes will be incremental and
gradual. This is similar to the work of others, for instance a
community pharmacy QI intervention study in the United
States found that after a follow-up period of 2 months, the
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study was unable to detect the impact either on quality-
related events or patient safety attitudes.[13]
Quality improvement should be a continuous process
involving a range of stakeholders[7] but our study suggested
not all pharmacists felt supported by their management
teams, particularly when they were wanting to trial new
ideas, suggesting that organisational value of the process and
advantages of using QI may be lacking. This is somewhat
unsurprising given that new ways of working do not easily
translate into practice.[33] Employers would be well-minded
to prioritise and encourage QI methods to allow pharmacy
teams to critically reflect and improve services and work
practices. The General Pharmaceutical Council should seek
to review training and competency requirements to promote
greater emphasis on demonstrating competence in QI
methodology. In the light of the COVID-19 pandemic,
which has seen significant changes to the way health profes-
sionals work,[34] policy makers should review how QI is
being framed, prioritised and implemented within practice
and advanced pharmacy education and training.[35] It would
be prudent to appraise and embed QI within any new role or
service and ensure additional resource is available for QI
training and development.
Conclusion
With NHS services facing financial pressures and significant
practice changes, the QI agenda is increasingly seen as an
important mechanism to improve safety, effectiveness and
patient experience. This study highlights that UK commu-
nity pharmacists may have limited skills or capacity to fully
embrace QI and its application in a manner that is recom-
mended. Postgraduate training and support could be one
way to address pharmacist deficit in knowledge in this area.
The QI module could be made available more widely to
improve pharmacists QI skills and to encourage best prac-
tices and improvements in patient care.
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